Holen Sie sich die Stockscreener-App
7.77
2.88%
-0.23
Schlusskurs vom Vortag:
$8.00
Offen:
$7.98
24-Stunden-Volumen:
1.34M
Relative Volume:
1.75
Marktkapitalisierung:
$533.29M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-96.66M
KGV:
-3.614
EPS:
-2.15
Netto-Cashflow:
$-83.73M
1W Leistung:
-6.50%
1M Leistung:
+46.33%
6M Leistung:
+72.28%
1J Leistung:
-34.43%
1-Tages-Spanne:
$7.75
$8.197
1-Wochen-Bereich:
$7.215
$8.52
52-Wochen-Spanne:
$2.86
$13.93
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
Firmenname
Olema Pharmaceuticals Inc
Sektor
Branche
Telefon
(415) 651-3316
Adresse
780 BRANNAN STREET, SAN FRANCISCO
Vergleichen Sie OLMA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
7.77 | 536.03M | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-12 | Bestätigt | Citigroup | Buy |
| 2024-04-02 | Eingeleitet | Goldman | Buy |
| 2024-01-30 | Eingeleitet | Citigroup | Buy |
| 2023-07-21 | Eingeleitet | Oppenheimer | Outperform |
| 2023-05-05 | Eingeleitet | CapitalOne | Overweight |
| 2023-02-22 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-06 | Fortgesetzt | Canaccord Genuity | Buy |
| 2022-06-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | Eingeleitet | H.C. Wainwright | Neutral |
| 2021-12-07 | Fortgesetzt | Cowen | Outperform |
| 2020-12-14 | Eingeleitet | Canaccord Genuity | Buy |
| 2020-12-14 | Eingeleitet | Cowen | Outperform |
| 2020-12-14 | Eingeleitet | JP Morgan | Overweight |
| 2020-12-14 | Eingeleitet | Jefferies | Buy |
Alle ansehen
Olema Pharmaceuticals Inc Aktie (OLMA) Neueste Nachrichten
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Rating Upgraded by Zacks Research - MarketBeat
What’s the recovery path for long term holders of Olema Pharmaceuticals Inc.2025 Performance Recap & Reliable Intraday Trade Plans - Newser
Price momentum metrics for Olema Pharmaceuticals Inc. explained2025 Earnings Surprises & Fast Moving Market Watchlists - Newser
Price action breakdown for Olema Pharmaceuticals Inc.2025 Short Interest & Reliable Price Action Trade Plans - Newser
Should you hold or exit Olema Pharmaceuticals Inc. nowGap Up & Expert Curated Trade Setups - Newser
Invesco Ltd. Raises Stake in Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Does Olema Pharmaceuticals Inc. show high probability of reboundForecast Cut & High Win Rate Trade Alerts - Newser
OLMA Stock Soars 47% in September So Far on Second PFE Deal - Yahoo Finance
What data driven models say about Olema Pharmaceuticals Inc.’s futureInsider Buying & Verified Entry Point Detection - Newser
Olema Pharmaceuticals Inc. recovery potential after sell offAnalyst Downgrade & Weekly High Momentum Picks - Newser
Olema Pharmaceuticals (NASDAQ:OLMA) Upgraded at Zacks Research - Defense World
Intraday pattern recognizer results for Olema Pharmaceuticals Inc.Gap Down & Free AI Powered Buy and Sell Recommendations - Newser
PDT Partners LLC Buys Shares of 74,299 Olema Pharmaceuticals, Inc. $OLMA - MarketBeat
Pfizer-Olema Collaboration Targets Metastatic Breast Cancer - MSN
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Heatmap analysis for Olema Pharmaceuticals Inc. and competitorsJuly 2025 Update & AI Optimized Trading Strategy Guides - Newser
Olema Pharmaceuticals (NASDAQ:OLMA) Shares Down 7.2%Should You Sell? - MarketBeat
HC Wainwright Issues Positive Forecast for OLMA Earnings - MarketBeat
Visualizing Olema Pharmaceuticals Inc. stock with heatmapsTrade Volume Report & Weekly Setup with ROI Potential - Newser
Published on: 2025-09-10 11:11:24 - Newser
Is Olema Pharmaceuticals Inc. showing signs of accumulationWeekly Stock Summary & Smart Money Movement Alerts - Newser
Real time alert setup for Olema Pharmaceuticals Inc. performance2025 Institutional Moves & Fast Exit Strategy with Risk Control - Newser
What MACD and RSI say about Olema Pharmaceuticals Inc.July 2025 Recap & Free Daily Entry Point Trade Alerts - Newser
Pfizer (PFE): Evaluating Valuation After New Oncology Partnership With Olema Pharmaceuticals - simplywall.st
Risk vs reward if holding onto Olema Pharmaceuticals Inc.Weekly Gains Report & Community Trade Idea Sharing - Newser
Will Olema Pharmaceuticals Inc. see short term momentumEarnings Risk Summary & Advanced Technical Analysis Signals - Newser
What machine learning models say about Olema Pharmaceuticals Inc.Weekly Profit Summary & Real-Time Buy Signal Notifications - Newser
What technical models suggest about Olema Pharmaceuticals Inc.’s comebackWeekly Trade Analysis & Low Volatility Stock Recommendations - Newser
Relative strength of Olema Pharmaceuticals Inc. in sector analysisWeekly Stock Summary & Consistent Income Trade Recommendations - Newser
Signal strength of Olema Pharmaceuticals Inc. stock in tech scannersWeekly Trading Summary & Weekly Return Optimization Plans - Newser
Olema Pharmaceuticals Inc. stock outlook for YEAR2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - Newser
Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High? - MSN
Is Olema Pharmaceuticals Inc. stock poised for growthTrade Performance Summary & Safe Entry Zone Identification - Newser
Is it too late to sell Olema Pharmaceuticals Inc.July 2025 Price Swings & Advanced Technical Analysis Signals - Newser
olema pharmaceuticals inc. stock retracement – recovery analysis2025 Market Overview & Free Real-Time Volume Trigger Notifications - Newser
What moving averages say about Olema Pharmaceuticals Inc.Day Trade & Capital Efficiency Focused Strategies - Newser
Olema Pharmaceuticals, Inc. $OLMA Holdings Cut by Bain Capital Life Sciences Investors LLC - MarketBeat
Olema Pharmaceuticals Inc. stock retracement – recovery analysisGap Up & Verified Entry Point Signals - Newser
Finanzdaten der Olema Pharmaceuticals Inc-Aktie (OLMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):